Dr. Ohmini Krishnamurthy Rajendran: Advancing Precision Oncology at the Intersection of Medicine, Artificial Intelligence, and Computational Science

Dr. Ohmini Krishnamurthy Rajendran: Advancing Precision Oncology at the Intersection of Medicine, Artificial Intelligence, and Computational Science

How an Indian physician-scientist is helping shape the future of precision oncology by bringing together radiology, artificial intelligence, genomics, computational biology, and translational medicine

Medicine has entered an era in which its most complex questions can no longer be answered by a single specialty.

Radiologists interpret medical images. Pathologists analyze tissue architecture. Molecular biologists decode genomic alterations. Oncologists translate these findings into treatment decisions. Today, artificial intelligence and computational science are increasingly connecting these disciplines, creating opportunities to understand cancer through integrated biological and clinical data rather than isolated diagnostic tests.

This convergence is reshaping precision oncology. As medical imaging, digital pathology, genomics, molecular profiling, and longitudinal clinical data become increasingly interconnected, researchers are developing more comprehensive approaches to understanding disease.

Among the physician-scientists contributing to this transformation is Dr. Ohmini Krishnamurthy Rajendran, an Indian Consultant Radiologist whose work spans clinical medicine, computational oncology, artificial intelligence, and translational research. Rather than viewing radiology simply as the endpoint of diagnosis, she investigates how imaging can be integrated with pathology, molecular biomarkers, genomic alterations, and clinical information to better characterize cancer biology and support more personalized care.

From Clinical Medicine to Computational Oncology

Many advances in computational medicine originate in engineering and data science. Dr. Rajendran's research, however, has been shaped by direct clinical experience.

Before specializing in radiology, she trained and practiced as a physician, gaining firsthand insight into diagnostic uncertainty, disease progression, and the complexities of patient care. Those experiences continue to influence her research philosophy that technology should enhance, rather than replace, clinical judgment.

Today, as a Consultant Radiologist in Bengaluru, her work includes diagnostic imaging, cancer staging, treatment-response assessment, image-guided procedures, multidisciplinary tumor boards, postgraduate education, and academic research. Working closely with clinicians across specialties has reinforced the importance of integrating radiological findings with pathology, laboratory investigations, molecular profiling, and clinical information to guide patient management.

That philosophy is reflected throughout her research, which explores computational frameworks designed to complement clinical reasoning through the integration of diverse biomedical data.

Building Intelligent Systems for Precision Oncology

One of oncology's greatest challenges is no longer collecting biomedical data but understanding how different forms of information relate to one another.

A major focus of Dr. Rajendran's research is radiogenomics, which investigates relationships between quantitative imaging characteristics and genomic alterations. The objective is to determine whether routine medical imaging can provide complementary, non-invasive insights into tumor biology.

Another area of investigation is multimodal artificial intelligence, where radiological images, pathology, genomic information, laboratory findings, and clinical records are analyzed together rather than independently. Integrating these datasets allows researchers to explore biological relationships that may remain hidden when each source is evaluated separately.

Interpretability is equally important. In studies involving therapeutic response prediction, including research related to osimertinib treatment in EGFR-mutated non-small cell lung cancer, Dr. Rajendran has explored explainable AI approaches that seek to make computational predictions transparent enough for clinicians to evaluate critically.

Her work also includes federated learning, enabling healthcare institutions to collaboratively develop artificial intelligence models while preserving patient privacy. Beyond imaging, she has investigated graph neural network–based computational pathology for characterizing tumor microenvironments and DeepDRA, a multi-omics framework designed to investigate therapeutic response prediction and opportunities for cancer drug repurposing.

Although these projects address different scientific questions, they share a common objective: transforming complex biomedical data into clinically meaningful knowledge that may contribute to more precise and individualized oncology care.

Looking Beyond Individual Algorithms

Artificial intelligence is evolving beyond individual predictive models toward integrated healthcare ecosystems capable of combining diverse forms of biomedical information.

Rather than focusing on a single technology, Dr. Rajendran's work examines how developments such as digital twins, foundation models, synthetic medical imaging, digital biomarkers, and intelligent clinical workflows may eventually converge into comprehensive computational platforms for precision oncology.

Digital twins—virtual computational representations of patients built from imaging, pathology, genomic profiles, laboratory investigations, physiological measurements, and longitudinal clinical information—may eventually allow researchers to simulate disease progression and evaluate personalized therapeutic strategies before treatment decisions are made.

She has also explored foundation models for medical imaging, which learn broad biomedical representations from large-scale datasets before being adapted to tasks such as tumor detection, disease characterization, treatment-response assessment, and multimodal clinical decision support.

Research into synthetic medical image generation addresses practical challenges including limited datasets, rare disease representation, class imbalance, and model validation through realistic image synthesis.

For Dr. Rajendran, however, successful healthcare innovation depends on more than technological capability. Physician acceptance, workflow integration, explainability, patient safety, regulatory oversight, and rigorous clinical validation remain essential for translating artificial intelligence into routine clinical practice.

Innovation Beyond Research

Scientific discovery represents only one step in advancing healthcare innovation.

Dr. Rajendran's emphasis on translation extends beyond academic publications into intellectual property focused on converting computational concepts into practical healthcare technologies. Her innovation portfolio includes intelligent diagnostic platforms, radiogenomic decision-support systems, digital twin architectures, imaging reconstruction technologies, and multimodal computational frameworks for precision oncology.

Scientific communication has become another important dimension of her work. Through books, peer-reviewed publications, invited chapters, and scientific reviews, she has sought to make emerging developments in artificial intelligence, radiology, computational biology, and precision oncology more accessible to clinicians and researchers working across disciplines.

She also contributes to the scientific community through peer review, invited lectures, conference presentations, editorial activities, and academic mentorship, reflecting the collaborative nature of modern biomedical research.

Beyond oncology, her interests extend into computational biology and space medicine. Using publicly available NASA Open Science datasets, she has explored genomic instability, transcriptomic alterations, DNA damage responses, and radiation biology associated with spaceflight, demonstrating how computational approaches developed for cancer research may also contribute to understanding human biology in extreme environments.

The Future of Medicine Is Connected

The future of precision medicine will depend not only on new discoveries but also on the ability to connect discoveries across disciplines.

As medical imaging, genomics, digital pathology, laboratory diagnostics, wearable technologies, and longitudinal clinical data continue to expand, one of healthcare's greatest opportunities will be transforming these diverse information sources into clinically meaningful insight. Achieving that goal will require clinicians, scientists, engineers, and computational researchers to work together in increasingly integrated ways.

Rather than being defined by a single technology or specialty, the next generation of precision medicine is likely to be shaped by the ability to bridge disciplines. Dr. Ohmini Krishnamurthy Rajendran's work reflects that broader shift—one in which clinical medicine, computational science, and biomedical innovation increasingly converge to advance more intelligent, data-driven, and personalized cancer care.

Her career illustrates a wider transformation in modern healthcare, where meaningful innovation is measured not only by scientific discovery but by its ability to improve clinical understanding, support better decision-making, and ultimately enhance patient outcomes.